HCA Healthcare, Inc.
HCA Healthcare
HCA · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $75.6B
- Assets
- $60.7B
- SEC filing
- DEF 14A
- Filed
- March 13, 2026
Executive Compensation
Compensation reported for HCA Healthcare’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Samuel N. Hazen
Chief Executive Officer
$26.5M
Reported total
- Salary
- $1,577,815
- Stock awards
- $8,474,543
- Incentives
- $5,416,732
- Option awards
- $8,514,090
- Other
- $2,473,426
Jon M. Foster
Executive Vice President And Chief Operating Officer
$11M
Reported total
- Salary
- $1,043,375
- Stock awards
- $1,903,173
- Incentives
- $2,558,549
- Option awards
- $1,911,848
- Other
- $3,575,841
Michael A. Marks
Executive Vice President
$10.4M
Reported total
- Salary
- $982,500
- Stock awards
- $1,776,295
- Incentives
- $2,422,729
- Option awards
- $1,784,399
- Other
- $3,389,188
Michael R. McAlevey
Executive Vice President - Chief Legal And
$5.7M
Reported total
- Salary
- $1,012,688
- Stock awards
- $1,268,782
- Incentives
- $1,986,638
- Option awards
- $1,274,603
- Other
- $167,624
Samuel N. Hazen
Chief Executive Officer
$26.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 13, 2026.
- Salary
- $1.6M
- Stock Awards
- $8.5M
- Option Awards
- $8.5M
- Incentives
- $5.4M
- Other
- $2.5M
Historical Compensation
Samuel N. Hazen total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,577,815 | $8,474,543 | $26,456,606 |
| 2024 | $1,539,947 | $8,421,948 | $23,799,137 |
| 2023 | $1,512,222 | $6,957,391 | $21,315,984 |
Named Executive Officers
Samuel N. Hazen
Chief Executive Officer
HCA Healthcare · HCA
$26.5M
FY 2025 · DEF 14A
Michael A. Marks
Executive Vice President
HCA Healthcare · HCA
$10.4M
FY 2025 · DEF 14A
Jon M. Foster
Executive Vice President And Chief Operating Officer
HCA Healthcare · HCA
$11M
FY 2025 · DEF 14A
Michael R. McAlevey
Executive Vice President - Chief Legal And
HCA Healthcare · HCA
$5.7M
FY 2025 · DEF 14A
Source information
- Company
- HCA Healthcare, Inc.
- Ticker
- HCA · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 13, 2026
- SEC accession number
- 0001193125-26-106142
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →